Pharmaceuticals

US Pharma and Biotech Summit 2024: When FDA needs to regulate AI

bexib
By bexib 0 Min Read

Tara Fakhoury spoke at the conference about the FDA’s approach to determining when the use of AI in the pharmaceutical industry needs to be regulated.

You Might Also Like

Research reveals link with malaria parasites developing anti-malarial drug resistance

Pharmaceutical’s “It” Therapy – A New Drug Class Gaining Momentum

Branch: Wegovy

Study finds pain genes influence success of chronic pain treatment in women

FDA Grants Emergency Use Authorization for Roche’s Cobas Riat SARS-CoV-2, Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Tests

Share This Article
Previous Article How To Start a Skin Care Line in 11 Steps (2024)
Next Article Infrastructure Week is no longer a punchline, but it hasn’t reached the stage either.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Is this episode a deep fake? -What is a brewing podcast (episode 9)
Insurance
Understanding Coverage Essentials for Businesses
Insurance
Direct hotel reservations that Kiwis prioritize
Hospitality & Tourism
Secretary of Commerce is seeking a “full” tariff
Manufacturing